NATIONAL CANCER CONTROL PROGRAMME
NOP online
ISSN 1802-887X
CANCON
 
data and background information All projects

All projects

CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control

CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control

Based on the Czech information system of cancer care, the Czech Republic has been selected as a model country for the development of a Comprehensive Cancer Care Network (CCCN).

CAR-TOOL

CAR-TOOL

The aim of the project is to collect and evaluate data from real clinical practice, which are related to the administration of CAR-T cell therapy in patients with certain hematological malignancies who face poor prognosis. CAR-T cell therapy is currently indicated in adult patients with certain types of non-Hodgkin's lymphoma, incl. aggressive, relapsing or refractory diffuse large B-cell lymphoma, primary mediastinal B-lymphoma, high-grade B-lymphoma, transformed follicular lymphoma and mantle cell lymphoma; and in pediatric patients and patients under 25 years of age with acute lymphoblastic leukemia (B-ALL) who do not respond to a defined number of standard therapy lines.

Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic

Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic

System of informational support for the Cervical Cancer Screening Programme in the Czech Republic.

CyRUS – Cystectomy Registry of the Czech Urological Society

CyRUS – Cystectomy Registry of the Czech Urological Society

Clinical registry monitoring cases of bladder cancers treated with cystectomy and consecutive treatment.

Data and projects of the Czech Society for Oncology

Data and projects of the Czech Society for Oncology

The Czech Society for Oncology (CSO) is the principal authority coordinating cancer-related activities in the Czech Republic.

I-COP: Information centre for cancer care facilities

I-COP: Information centre for cancer care facilities

Informational and analytical platform enabling the evaluation of complex aspects of health care provided to cancer patients in particular.

Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic

Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic

System of informational support for the Colorectal Cancer Screening Programme in the Czech Republic.

Mamo.cz – Breast Cancer Screening Programme in the Czech Republic

Mamo.cz – Breast Cancer Screening Programme in the Czech Republic

System of informational support for the Breast Cancer Screening Programme in the Czech Republic.

NOP On-line

NOP On-line

Project based on the development of a web portal containing detailed information on cancer care provided in the Czech Republic and on current nationwide projects focused on cancer prevention and cancer research.
Pemetrexed

Pemetrexed

Clinical registry of pleural mesothelioma patients who have been treated with pemetrexed (Alimta®).

PET/CT-CZ(Q)

PET/CT-CZ(Q)

Terminated project developing a data background for the monitoring of numbers and indications of PET/CT scans in the clinical practice of Czech health care facilities.

reGISTer

reGISTer

Terminated clinical registry that monitored the epidemiology of gastrointestinal stromal tumours (GIST) as well as therapeutic approaches and treatment results in GIST patients in the Czech Republic and Slovakia.

Rektum.cz

Rektum.cz

The portal rektum.cz is dedicated mainly to the education of health care professionals on the issue of rectal cancer, which is diagnosed as C20 under the ICD-10 classification.

SVOD: Cancer epidemiology in the Czech Republic

SVOD: Cancer epidemiology in the Czech Republic

Research project based on the development of a web portal about the cancer epidemiology in the Czech Republic. Its primary objective is to provide access to these valuable data to a wide spectrum of users from the Czech Republic as well as from abroad.

Tulung

Tulung

Clinical registry of non-small cell lung cancer (NSCLC) patients who have been treated with bevacizumab (Avastin®), erlotinib (Tarceva®), gefitinib (Iressa®), pemetrexed (Alimta®), afatinib (Giotrif®) and/or nintedanib (Vargatef®).

Uroweb

Uroweb

Presentation of data and strategic importance in the Czech urology as regards the treatment of urological malignancies.